Undisclosed antiretroviral drug use in Botswana: implication for national estimates

AIDS. 2018 Jul 17;32(11):1543-1546. doi: 10.1097/QAD.0000000000001862.

Abstract

: Among 3596 HIV-positive participants enrolled in the Botswana Combination Prevention Project who self-reported no prior antiretroviral (ARV) therapy use and were tested for viral load (n = 951; 27% of all participants), 136 (14%) had HIV-1 RNA less than 400 copies/ml. ARV drugs were detected in 52 (39%) of 134 participants tested. Adjusting for undisclosed ARV use increased the overall estimate of virally suppressed individuals on ARV therapy by 1.4% from 70.2 to 71.6%.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Anti-Retroviral Agents / blood
  • Anti-Retroviral Agents / therapeutic use*
  • Botswana
  • Female
  • HIV Infections / drug therapy*
  • HIV-1 / isolation & purification*
  • Humans
  • Male
  • Middle Aged
  • RNA, Viral / blood*
  • Treatment Outcome
  • Viral Load*
  • Young Adult

Substances

  • Anti-Retroviral Agents
  • RNA, Viral